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Abstract
A  50-year-old female patient is described with an acquired, persisting and yet 
incurable erythermalgia featured by symmetric burning pain and red congestion 
o f  the extremities secondary to cutaneous vasculitis, A weakly positive antinu- 
clear antibody titer and high titers o f  antibodies against gastric parietal m ucosa 
cells pointed to an underlying but unclassiliable autoimmune disorder. It is con ­
cluded that histopathology of  lesional skin contributes to the differential d iagno­
sis of primary and secondary erythermalgia.
Introduction responds to treatment o f  the underlying disorder or d iscon­
tinuation o f  the incriminated drug 11, 8, 10, 111.
Erythromelalgia and erythermalgia are two distinct clin- There also appears to be a persisting and incurable form
ical syndromes of  burning painful and red congested of erythermalgia arising at the adult age ( 12|. However, the
extremities [1 -3 ] .  The curable variant erythromelalgia is histopathology o f  incurable erythermalgia at the adult age
causally related to thrombocythemia and results from plate- has never been investigated. We have had the opportunity
let-mediated arteriolar inflammation and thrombosis. Aspi- to study an adult woman who developed incurable eryther-
rin completely alleviates all symptoms by irreversible inhi- malgia in the setting o f  an unclassiliable au to im m une disor-
bition of platelet cyclooxygenase activity and aggregation der. Evidence is presented that the specific clinical manifes-
[4 -7 ] . tations and the histopathological findings contribute to the
T he incurable variant of primary erythermalgia is a rare differential diagnosis o f  primary and secondary erythermal- 
congenital disorder which spontaneously arises in child- gia. 
hood or adolescence as bilateral symmetrically burning 
extremities in the absence of detectable disease [8, 9]. The
histopathology in primary erythermalgia is nonspecific and 
may show  only slight perivascular infiltration with lympho­
cytes [9].
Secondary erythermalgia usually arises at the adult age 
either in association with cutaneous vasculitis or with the 
use o f  drugs. Secondary erythermalgia in these conditions
Case Report
Since 1984, a 50-year-old woman has suffered from a unilateral 
painful erythema on the left heel, progressively extending to the foot, 
ankles and lower leg. In 1986, an erythema of the right foot, ankle and 
lower leg was noted. The condition progressed to bilateral burning 
distress and red swelling of both feet, ankles and lower legs. Since
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legs became a symmetric feature. At this stage, the symp- cells consistent with (peri)vasculitis, being different iron
toms superficially resembled the features of primary ery- fibromuscular proliferation and thrombotic occlusions ii
thermalgia [9], As in primary erythermalgia, the lesions had erythromelalgia [7J.
a bilateral distribution, there was aggravation by excercise This pattern is similar to the histopathology ot reportei
and elevation of the ambient temperature worsened the cases in erythermalgia secondary to vasculitis, systemi<
symptoms. Also, the slight relief by cold, rest and elevation lupus erythematosus in particular [10, 11], Laboratory test
of the affected extremities and the resistance to treatment fit ing in our patient revealed a high antinuclear antibody tite
with the diagnosis of primary erythermalgia. However, par- and antibodies against gastric parietal mucosa cells whicl
ticular symptoms are against the diagnosis of primary ery- suggests a coexisting, but not yet clearly defined, autoim
thermalgia and are more in agreement with a secondary mune disorder. It is not clear whether the autoimmunity ii
variant: the complaints and signs started as a unilateral pro- our patient establishes a significant pathogenetic factor o
cess and spread subsequently to both feet and hands, even a link.
whereas in primary erythermalgia the discomfort always In this respect, it should be noted that antinuclear anti
starts bilaterally as a symmetric process. In contrast to a bodies can be found in 10-37% of the healthy elderly an<
typical fluctuating course with frank exacerbations and parietal cell antibodies are seen in up to 16% of the norma
symptom-free periods in primary erythermalgia, the symp- population [14, 15]. In another case of severe adult-onse
toms in our patient became a constant and chronic clinical erythermalgia, no autoantibodies were detectable [12], Per
feature without any fluctuations. Moreover in our patient sisting (secondary) erythermalgia arising at the adult age i,
symptoms started at adult age unlike primary erythermal- very rare, and treatment is difficult. Histopathologica
gia. Histopathology of erythermalgic skin showed perivas- examination of lesional skin contributes to the differentia
cular inflammatory infiltrates of lymphocytes and plasma diagnosis of primary and secondary erythermalgia.
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